Top Markets
Coin of the day
Genex Pharmaceutical, Inc. Genex Pharmaceutical, Inc.

Genex Pharmaceutical, Inc.

GENX
Rank in Stocks #42367
Genex Pharmaceutical, Inc. engages in the development and production of... Genex Pharmaceutical, Inc. engages in the development and production of Reconstituted Bone Xenograft, which is a medical device that accelerates bone healing. The company was founded on February 28, 2002 and is headquartered in Tianjin, China.
Share Price
$0.0001
Last synced: 2026-08-11
Market Cap
$1.79K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
CN
Trade Genex Pharmaceutical, Inc. (GENX)

Category

Revenue for Genex Pharmaceutical, Inc. (GENX)
Revenue in Aug 2026 TTM: 0
According to Genex Pharmaceutical, Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Genex Pharmaceutical, Inc. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors